Monitoring Humana Inc. (HUM) after recent insider movements

0
1

Humana Inc.’s filing revealed that its Seg Pres, Pharmacy Sol & CCAO Fleming William Kevin unloaded Company’s shares for reported $6.31 million on Nov 03. In the deal valued at $565.61 per share,11,157 shares were sold. As a result of this transaction, Fleming William Kevin now holds 2,542 shares worth roughly $ 1.41 million.


3 Tiny Stocks Primed to Explode The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.

We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.

Click here for full details and to join for free.

Sponsored


Then, Diamond Susan M sold 5,623 shares, generating $3,184,030 in total proceeds. Upon selling the shares at $566.25, the Chief Financial Officer now owns 2,284 shares.

Before that, Ventura Joseph C sold 3,155 shares. Humana Inc. shares valued at $1,783,442 were divested by the Chief Legal Officer at a price of $565.27 per share. As a result of the transaction, Ventura Joseph C now holds 3,701 shares, worth roughly $2.05 million.

Deutsche Bank upgraded its Humana Inc. [HUM] rating to a Buy from a a Hold in a research note published on Monday, October 26, 2022; the price target was increased to $576 from $514. PT values the company’s stock at a premium of 3.66 to its Monday closing price. A number of analysts have revised their coverage, including Morgan Stanley’s analysts, who increased its forecast for the stock in mid September from “an Equal-weight” to “an Overweight”. Loop Capital began covering HUM with “Buy” recommendation on June 17, 2022. Bernstein started covering the stock on May 27, 2022. It rated HUM as “a Mkt perform”.

Price Performance Review of HUM

On Monday, Humana Inc. [NYSE:HUM] saw its stock jump 0.52% to $554.93. On the same session, the stock had its day’s lowest price of $548.10, but rose to a high of $557.42. Over the last five days, the stock has lost -0.56%. Humana Inc. shares have risen nearly 19.63% since the year began. Nevertheless, the stocks have risen 22.38% over the past one year. While a 52-week high of $571.30 was reached on 11/03/22, a 52-week low of $351.20 was recorded on 01/07/22. SMA at 50 days reached $504.56, while 200 days put it at $463.05. A total of 1.39 million shares were traded, compared to the trading of 0.17 million shares in the previous session.

Levels Of Support And Resistance For HUM Stock

The 24-hour chart illustrates a support level at 549.55, which if violated will result in even more drops to 544.16. On the upside, there is a resistance level at 558.87. A further resistance level may holdings at 562.80. The Relative Strength Index (RSI) on the 14-day chart is 69.25, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 17.51, which suggests price will go up in the next trading period. Percent R suggests that price movement has been bullish at 21.40%. Stochastics %K at 80.86% indicates the stock is a selling.

How much short interest is there in Humana Inc.?

A steep rise in short interest was recorded in Humana Inc. stocks on Jul 14, 2022, growing by 60000.0 shares to a total of 1.61 million shares. Yahoo Finance data shows the prior-month short interest on Jun 14, 2022 was 1.55 million shares. There was a rise of 3.73%, which implies that there is a positive sentiment for the stock. In spite of short shares comprising just 1.28% of the overall stock float, the days-to-cover ratio (short ratio) rose to 1.52.

Humana Inc. [HUM] – Who Are The Largest Shareholders?

In filings from The Vanguard Group, Inc., it is revealed that the company now owns 10,515,734 shares, or roughly 8.31% of the outstanding HUM shares. In other words, the investor’s shares have risen by 95,256 from its previous 13-F filing of 10420478.0. Additionally, Wellington Management Co. LLP increased 7.08% of its stake after which the total value it holdings stand at $4,559,095,113, while T. Rowe Price Associates, Inc. reduced -13.85% of its stake to hold $3.67 billion in the firm. Over the last quarter, BlackRock Fund Advisors purchased 106,243 shares of Humana Inc., while Fidelity Management & Research Co bought 30,791 shares. At present, SSgA Funds Management, Inc. is holding 5,559,655 shares valued at $2.7 billion. Capital Research & Management Co owned 3,890,140 shares of the company at the time of its most recent 13F filing, worth $1.89 billion.

According to FactSet, Humana Inc.’s share price will average $604.82 in the next year, based on opinions of analysts polled by the firm. This is up nearly 12.31 percent from its previous closing price of $552.05. Analysts expect Humana Inc. stock to reach the higher price of $650.00, while the lowest price estimate is $450.00. However, 25 analysts have rated HUM stock as a Buy in their predictions for 2022.

LEAVE A REPLY

Please enter your comment!
Please enter your name here